X4 PHARMACEUTICALS INC (XFOR) Forecast, Price Target & Analyst Ratings

NASDAQ:XFOR • US98420X2027

Current stock price

4.07 USD
+0.02 (+0.49%)
At close:
4.07 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for X4 PHARMACEUTICALS INC (XFOR).

Forecast Snapshot

Consensus Price Target

Price Target
$11.90
+ 192.38% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Apr 29, 2026
Period
Q1 / 2026
EPS Estimate
-$0.20
Revenue Estimate
3.264M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
86.67%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$11.90
Upside
+ 192.38%
From current price of $4.07 to mean target of $11.90, Based on 9 analyst forecasts
Low
$10.10
Median
$12.24
High
$13.65

Price Target Revisions

1 Month
25.00%
3 Months
45.83%

Price Target Summary

9 Wall Street analysts provided a forecast for the next 12 months for XFOR. The average price target is 11.9 USD. This implies a price increase of 192.38% is expected in the next year compared to the current price of 4.07.
The average price target has been revised upward by 45.83% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

XFOR Current Analyst RatingXFOR Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

XFOR Historical Analyst RatingsXFOR Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
86.67%
XFOR was analyzed by 9 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about XFOR.
In the previous month the buy percentage consensus was at a similar level.
XFOR was analyzed by 9 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-09GuggenheimInitiate Buy
2025-12-05StifelMaintains Buy -> Buy
2025-11-10HC Wainwright & Co.Maintains Buy -> Buy
2025-08-29StifelMaintains Buy -> Buy
2025-08-13HC Wainwright & Co.Maintains Buy -> Buy
2025-05-02HC Wainwright & Co.Maintains Buy -> Buy
2025-03-27HC Wainwright & Co.Reiterate Buy -> Buy
2025-03-26Cantor FitzgeraldReiterate Overweight -> Overweight
2025-02-07HC Wainwright & Co.Reiterate Buy -> Buy
2025-01-14HC Wainwright & Co.Reiterate Buy -> Buy
2024-11-14StifelMaintains Buy -> Buy
2024-11-14HC Wainwright & Co.Maintains Buy -> Buy
2024-06-28HC Wainwright & Co.Reiterate Buy -> Buy
2024-05-31Cantor FitzgeraldReiterate Overweight -> Overweight
2024-04-30HC Wainwright & Co.Maintains Buy -> Buy
2024-03-22HC Wainwright & Co.Reiterate Buy -> Buy
2023-12-12B. Riley SecuritiesDowngrade Buy -> Neutral
2023-08-11HC Wainwright & Co.Reiterate Buy -> Buy
2023-05-17StifelMaintains Buy -> Buy
2023-05-05HC Wainwright & Co.Reiterate Buy
2023-04-10B. Riley SecuritiesMaintains Buy
2023-03-24OppenheimerMaintains Outperform
2023-03-22Cantor FitzgeraldMaintains Overweight
2023-03-22HC Wainwright & Co.Maintains Buy
2022-12-22Cantor FitzgeraldInitiate Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
Apr 29, 2026
Period
Q1 / 2026
EPS Estimate
-$0.20
Revenue Estimate
3.264M
Revenue Q2Q
-88.67%
EPS Q2Q
-610.00%
Number of Analysts
5

Next Earnings Revisions

Revenue (1 Month)
-34.69%
Revenue (3 Months)
-17.95%
EPS (1 Month)
13.04%
EPS (3 Months)
15.49%

Next Earnings Summary

XFOR is expected to report earnings on 4/29/2026. The consensus EPS estimate for the next earnings is -0.2 USD and the consensus revenue estimate is 3.26M USD.
The next earnings revenue estimate has been revised downward by 17.95% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2032

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
XFOR revenue by date.XFOR revenue by date.
2.557M35.113M
1,273.21%		8.194M
-76.66%		7.344M
-10.37%		108.48M
1,377.12%		297.02M
173.80%		589.21M
98.37%		256.24M
-56.51%		622.58M
142.97%
EBITDA
YoY % growth
XFOR ebitda by date.XFOR ebitda by date.
-107.103M
-22.31%		-140.605M
-31.28%		-85.606M
39.12%		N/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
XFOR ebit by date.XFOR ebit by date.
-107.522M
-22.07%		-141.401M
-31.51%		-86.883M
38.56%		-105.322M
-21.22%		-112.933M
-7.23%		-68.675M
39.19%		85.202M
224.07%		282.6M
231.68%		199.28M
-29.48%		336.02M
68.62%
Operating Margin
XFOR operating margin by date.XFOR operating margin by date.
N/A-5,529.96%-247.44%-1,285.35%-1,537.75%-63.31%28.69%47.96%77.77%53.97%
EPS
YoY % growth
XFOR eps by date.XFOR eps by date.
-18.00
67.91%		-21.30
-18.33%		-4.34
79.62%		-1.11
74.46%		-1.05
5.22%		-0.38
63.59%		0.53
238.67%		1.74
227.88%		0.87
-50.15%		2.67
208.24%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.20
-610.00%		-0.21
93.83%		-0.22
67.48%		-0.25
-12.82%
Revenue
Q2Q % growth		3.264M
-88.67%		1.598M
-19.01%		1.666M
-5.61%		1.7M
-33.80%
EBITDA
Q2Q % growth		N/AN/AN/AN/A
EBIT
Q2Q % growth		-25.568M
-170.76%		-26.962M
-2.78%		-28.288M
-2.83%		-31.518M
-32.99%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

XFOR Yearly Revenue VS EstimatesXFOR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2020 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M
XFOR Yearly EPS VS EstimatesXFOR Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -500 -1K -1.5K -2K

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
24.11%
EPS Next 5 Year
19.14%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
45.90%
Revenue Next 5 Year
75.96%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

X4 PHARMACEUTICALS INC / XFOR Forecast FAQ

What is the price target for XFOR stock?

9 analysts have analysed XFOR and the average price target is 11.9 USD. This implies a price increase of 192.38% is expected in the next year compared to the current price of 4.07.

What is the next earnings date for XFOR stock?

X4 PHARMACEUTICALS INC (XFOR) will report earnings on 2026-04-29.

What are the consensus estimates for X4 PHARMACEUTICALS INC (XFOR) next earnings?

The consensus EPS estimate for the next earnings of X4 PHARMACEUTICALS INC (XFOR) is -0.2 USD and the consensus revenue estimate is 3.26M USD.

Can you provide the analyst count for X4 PHARMACEUTICALS INC stock?

The number of analysts covering X4 PHARMACEUTICALS INC (XFOR) is 9.